A detailed history of Breakwater Capital Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Breakwater Capital Group holds 2,653 shares of AZN stock, worth $220,384. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,653
Holding current value
$220,384
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$66.81 - $80.83 $177,246 - $214,441
2,653 New
2,653 $207 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $257B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Breakwater Capital Group Portfolio

Follow Breakwater Capital Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breakwater Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Breakwater Capital Group with notifications on news.